Pharmacelsus gets involved in antifungal research: new FP7 project “NOFUN - Novel antifungals against resistant organisms"
November 7, 2013
The aim of the 3 year-funded collaborative project is the development of new antifungals against species, such as Aspergillus, Candida, Cryptococcus or Pneumocystis which manifest an increasing resistance towards antifungal agents available on the market.
Three SMEs (F2G, UK; OnTarget Chemistry, Sweden and Pharmacelsus, Germany) and two academic partners (University of Manchester, UK and University Rovira I Virgili, Spain) combine their expertise in medicinal chemistry and preclinical research to deliver several drug candidates suitable for clinical development.
More information available at www.nofunproject.eu